Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August
Oslo, Norway, 14 August 2017 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its second quarter and first half 2017 results on Thursday, 24 August 2017. A presentation by Targovax's management to investors, analysts and the press will take place in Oslo at 10:00 CET. The results report and the presentation will be available at www.targovax.com in the Investors section from 07:00 CET. PresentationThe presentation will take place at 10:00 CET at: Hotel ContinentalStortingsgaten 24/260117